Rapid metabolic changes accompany B cell activation. To assess metabolic changes in B cells following stimulation through the BCR via a polyclonal antibody specific for immunoglobulin M (anti-IgM) or through TLR9 via the TLR9 agonist CpG, we carried out metabolic stress tests 15 . We plated purified mouse splenic B cells into the wells of an extracellular flux analyzer to measure, in real B cells are activated by two temporally distinct signals, the first provided by the binding of antigen to the B cell antigen receptor (BCR), and the second provided by helper T cells. Here we found that B cells responded to antigen by rapidly increasing their metabolic activity, including both oxidative phosphorylation and glycolysis. In the absence of a second signal, B cells progressively lost mitochondrial function and glycolytic capacity, which led to apoptosis. Mitochondrial dysfunction was a result of the gradual accumulation of intracellular calcium through calcium response-activated calcium channels that, for approximately 9 h after the binding of B cell antigens, was preventable by either helper T cells or signaling via the receptor TLR9. Thus, BCR signaling seems to activate a metabolic program that imposes a limited time frame during which B cells either receive a second signal and survive or are eliminated. UT 2-DG (lo) 2-DG (hi) Oligo US CpG A nti-IgM C pg + anti-lgM NATuRE IMMuNology | VOL 19 | AUGUST 2018 | 871-884 | www.nature.com/natureimmunology
A ntigen-specific antibody responses are initiated by the binding of antigens to B cell antigen receptors (BCRs). Antigen binding alone initiates a cascade of signaling events that for many antigens is necessary but not sufficient to drive full activation of B cells, including proliferation and differentiation into antibodysecreting cells. For these antigens, full activation requires that B cells acquire a temporally distinct second signal. Second signals are provided by antigen-specific helper T cells following the processing of antigen by B cells and the presentation of antigen by B cells to antigen-specific helper T cells, which results in the formation of an immunological synapse [1] [2] [3] [4] . Ultimately, the engaged helper T cell provides a critical second signal for the B cells through binding of the costimulatory receptor CD40, expressed by B cells, to its ligand CD40L, on the helper T cells 5 . Second signals can also be delivered through pattern-recognition receptors (PRRs) in the absence of T cells [6] [7] [8] . The PRR TLR9, which responds to unmethylated CpG oligonucleotides present in microbial genomes 9 , provides particularly potent survival and differentiation signals to antigen-activated B cells.
The requirement for the acquisition of a second signal is a fundamental immunological control mechanism that ensures that in the absence of antigen-specific helper T cells or pathogen products, antigen binding alone will not promote the proliferation of B cells and their differentiation into antibody-secreting cells. Despite the central role of the requirement for two signals in the generation of antibody responses, there is incomplete understanding of the molecular nature of the consequences of each signal on B cells and the effect of the failure to acquire a second signal.
The requirements for the activation of lymphocytes are being increasingly viewed in the context of the transition of cells from a resting state to a highly active one. It is now appreciated that the switch from a quiescent cell to a rapidly growing one requires metabolic reprogramming in order to both fuel the energy requirements of highly active cells and provide intermediates for biosynthesis 10-12 . Published studies have provided evidence that although B cells are able to consume glucose and fatty acids as sources of energy and for resting-state biosynthesis, B cells stimulated through the BCR increase their glycolysis and expression of the glucose transporter GLUT1 through mechanisms dependent on the cell-cycle regulator c-Myc and the lipid kinase PI3K ('phosphatidylinositol-3-OH kinase') 10, 11, 13 but, in addition, continue to use oxidative phosphorylation 11 . The BCR-mediated boost in the utilization of glucose is blunted by the inhibitory receptor Fcγ RIIB 13 and by the induction of hypo-responsive B cell states such as anergy 10 . The utility of understanding the metabolic demands on B cells during activation has been highlighted by published studies showing that B cell-specific diversion of glucose carbons from glycolysis to the pentose-phosphate pathway provides a target for the treatment of B cell malignancies 14 .
Here we provide the results of an extensive study of the metabolic reprogramming of activated B cells in which we discovered that the binding of antigen to the BCR activates a 'metabolic clock' that limits the time during which B cells must receive a second signal to survive. time, changes in the B cells' oxygen-consumption rate (OCR), an indicator of oxidative phosphorylation (Fig. 1a) , and their extracellular acidification rate (ECAR), an indication of the production of lactate during glycolysis (Fig. 1b ). Stimulation of B cells with either CpG or anti-IgM or with both induced a rapid increase in both the OCR and the ECAR (Fig. 1a,b ). The addition of oligomycin resulted in a drop in the OCR (Fig. 1a) , and the subsequent addition of the uncoupler 2,4-DNP (2,4-dinitrophenol) depolarized the mitochondrial membrane, which resulted in an increase in the OCR. The difference between the OCR at baseline and the OCR after the addition of 2,4-DNP represents the spare oxidative phosphorylation capacity of the cells; these values were similar in the various stimulation conditions (Fig. 1a ). The addition of oligomycin to the wells also resulted in an increase in the ECAR (Fig. 1b) ; the difference in the ECAR before treatment with oligomycin and the ECAR after treatment with oligomycin represents the augmented glycolytic reserves of the B cells, and these were similar in all cases.
BCR-induced increases in maximal OCR were blocked in the presence of the following kinase inhibitors: the Syk inhibitor piceatannol, the Btk inhibitor ibrutinib, the PI3K inhibitor wortmannin or the JNK inhibitor SP600125 (Fig. 1c ). This directly linked BCR signaling to metabolic changes. TLR9-induced increases in OCR were unaffected, which suggested that TLR9 signaling was too robust or too redundant to be affected by the inhibitors used.
To determine if the immediate increases in the OCR and ECAR required cellular remodeling, we measured changes in mitochondrial membrane potential, expression of the glucose transporters GLUT1 and GLUT3, the uptake of glucose and mitochondrial mass during the first 4 h after stimulation (as described above). None of these parameters showed a significant difference in unstimulated B cells relative to that in stimulated B cells ( Supplementary Fig. 1 ).
To gain insight into the metabolic reprogramming that occurs in activated B cells, we used RNA-based next-generation sequencing (RNA-seq) to assess changes in gene expression that occurred within the first 4 h following stimulation with CpG or anti-IgM or both CpG and anti-IgM, or no stimulation (medium alone) 16 , focusing on changes in the expression of genes encoding enzymes associated with cellular metabolism ( Supplementary Fig. 2 ). Overall, the patterns of differential gene expression (different in stimulated B cells relative to that in cultured, unstimulated B cells) were similar for treatment with CpG or anti-IgM or both (Fig. 1d ). Two observations were notable. First, the transcription of genes encoding key enzymes in glycolysis, including hexokinase (Hk2) and lactate dehydrogenase A (Ldha) ( Supplementary Fig. 2 ), was upregulated ( Fig. 1d) , consistent with the observed increase in glycolysis. Second, the transcription of genes (Pdha1 and Pdhb) that encode subunits of the enzyme pyruvate dehydrogenase (PDH), which catalyzes pyruvate to acetyl CoA ( Supplementary Fig. 2 ), was not affected by any stimulation (Fig. 1d ); this suggested that anaerobic glycolysis might be favored over glucose oxidation in activated B cells. However, the transcription of genes (Pdp1 and Pdp2) encoding phosphatases that dephosphorylate and activate PDH was upregulated, and the transcription of genes (Pdk1 and Pdk2) encoding kinases that phosphorylate and inactivate PDH was downregulated ( Fig. 1d and Supplementary Fig. 2 ). We quantified PDH activity in lysates of B cells cultured in vitro for 6 h after stimulation and found that each stimulant increased the PDH activity similarly, relative to the PDH activity of unstimulated B cells (Fig. 1e ), indicative of an increase in glucose oxidation. Thus, we concluded that although B cells responded to stimulation via the BCR or TLR9 by increasing both glycolysis and oxidative phosphorylation, relying on the existing glucose-uptake machinery and mitochondrial contents, they began a process of cellular remodeling to increase mitochondrial and glycolytic capacities as early as 4 h after activation, and also that the shift toward anaerobic glycolysis was not complete and B cells continued to use oxidative phosphorylation to obtain energy from glucose.
Metabolic requirements for early antigen-induced BCR function. The observed rapid increases in both oxidative phosphorylation and glycolysis following B cell stimulation led us to investigate whether both metabolic pathways were equally required for early BCR signaling events and BCR internalization. To evaluate signaling, we obtained B cells from MD4 mice, which have transgenic expression of a BCR specific for hen egg lysozyme (HEL), placed the cells on planar lipid bilayers (PLBs) containing HEL in the presence or absence of an inhibitor of glycolysis (2-DG (2-deoxyglucose)) or of oxidative phosphorylation (oligomycin) 17 , and imaged the cells by total internal reflection fluorescence microscopy. In the absence and/or anti-IgM (5 μ g/ml) (key) and treated with oligomycin (Oligo), 2,4-DNP (DNP) and antimycin and rotenone (A&R); downward arrows indicate treatment times. Data are from three independent experiments with ten pooled, individual samples (mean ± s.e.m.). c, Maximum OCR in B cell cultures to which no inhibitor (None) or inhibitors of various kinases (horizontal axis) were added immediately after stimulation as in a,b (key), assessed after the addition of 2,4-DNP. Each symbol represents an individual sample. Data are pooled from two experiments with ten individual samples. d, RNA-seq data 16 of the expression of a set of genes (left margin) encoding molecules involved in glucose or fatty-acid metabolism in purified mouse splenic B cells cultured in triplicate for 4 h in medium containing CpG (1 μ M) and/ or anti-IgM (5 μ g/ml) (above plot); results (log 2 fold values) are presented relative to those of cells cultured in medium alone. e, PDH activity in B cells cultured for 6 h in medium alone (unstimulated) or in medium containing CpG alone, anti-IgM alone or both, assessed by colorimetric assay of the absorbance of the reporter dye WST-1, relative to that at time 0, set as 1. Data are representative of two experiments. f, Live-cell time-lapse total internal reflection fluorescence microscopy of HEL-specific MD4 B cells labeled with DyLight 549-conjugated Fab anti-IgM (to allow imaging of the BCRs) and placed on HEL-containing PLBs without metabolic inhibitors (untreated (UT)) or with either 2-DG (55 mM) or oligomycin (6 μ M) (left margin); images were acquired for 30 min at 37 °C. Scale bar (bottom left), 10 µ m. Data are representative of two experiments. g, Accumulation of BCRs in the contact area of the B cell with the HEL-containing PLB in the absence (UT) or presence of a high concentration (55 mM) of 2-DG (hi) or 6 μ M oligomycin (key in i), presented as the mean fluorescence intensity of the BCR above background (fold values), over time (horizontal axis). Data are representative of two experiments (mean ± s.d.). h, Contact area of the B cell with the HEL-containing PLB in conditions as in g (key in i). Data are representative of two experiments (mean ± s.d.). i, Mean fluorescence intensity (MFI) of pHrodo over time (horizontal axis) in HEL-specific MD4 B cells incubated with pHrodo-conjugated HEL on ice, then warmed to 37 °C in the absence (UT) or presence of a standard concentration (11 mM) of 2-DG (lo), a high concentration (55 mM) of 2-DG (hi) or 6 μ M oligomycin (key); results are presented relative to those at time 0. Data are representative of three independent experiments (mean ± s.d. of three biological replicates). j, Viability of purified mouse splenic B cells incubated in medium alone (US) or in medium containing CpG (1 μ M) and/or anti-IgM (5 μ g/ml) (key) in the absence (UT) or presence of 2-DG (11 nM) and/or oligomycin (6 μ M) (above plots), assessed over time (horizontal axis) by flow cytometry after staining with LIVE/DEAD dye. Data are pooled from two independent experiments (mean ± s.e.m. of six biological replicates). P values (colors match key where applicable; asterisks or adjusted P values), versus unstimulated B cells (c,e) or cells without inhibitor (g-j): NS, not significant (P > 0.05); *0.01 < P ≤ 0.05, **0.001 < P ≤ 0.01, ***0.0001 < P ≤ 0.001 and ****P ≤ 0.0001 (one-way analysis of variance (ANOVA) with Tukey's adjustment (c), linear regression (e), cubic regression with Bonferroni's adjustment (g,h) or two way ANOVA with Dunnet's adjustment (i,j)). of either inhibitor, B cells rapidly spread over the HEL-containing PLB and accumulated BCRs in the contact area ( Fig. 1f-h ). Neither spreading nor BCR accumulation was diminished by the inhibition of glycolysis; however, both processes required oxidative phosphorylation and were inhibited by oligomycin ( Fig. 1f -h).
To quantify antigen internalization, we incubated HELspecific B cells with HEL conjugated to pHrodo, a pH-sensitive fluorescent dye that allows the monitoring of the internalization of HEL and its progression through intracellular acidic compartments. Neither a standard concentration of 2-DG (11 mM) nor a high concentration of 2-DG (55 mM) affected the increase in pHrodo, whereas oligomycin blocked the increase in pHrodo ( Fig. 1i and Supplementary Fig. 3a ), which indicated a block in the internalization of HEL and its trafficking to acidic compartments. 20 28 Time (h) 44 51 0246 12 20 28 Time (h) 44 51 0246 12 20 28 Time (h) 44 51 0246 12 20 28 Time (h) 44 Thus, the energy for the early events following the contact of B cells with antigen was provided mainly by oxidative phosphorylation, not by glycolysis.
Only TLR9 signaling promotes B cell survival. We determined the metabolic requirements for the proliferation and long-term survival (up to 51 h) of B cells induced by anti-IgM and/or CpG. We observed no cell division at 24 h for any stimulation condition; however, by 48 h, the majority of B cells stimulated with CpG alone or with CpG plus anti-IgM had divided at least twice, in contrast to B cells stimulated with anti-IgM alone, among which very few had undergone more than a single round of division ( Supplementary  Fig. 3b,c) . B cells treated with anti-IgM alone maintained low viability throughout the 51-hour time course, similar to unstimulated B cells, as measured with a fluorescent dye that distinguishes live cells from dead cells (LIVE/DEAD dye) ( Fig. 1j ). Cell death for both stimulation with anti-IgM and no stimulation was nearly exclusively from apoptosis and not from necrosis, as determined by staining with the membrane-impermeable DNA-intercalating dye 7-AAD and the fluorescent caspase inhibitor FAM FLICA ( Supplementary Fig. 4a,b ). In contrast, B cells treated with CpG alone or with CpG plus anti-IgM maintained over 70% viability. For B cells stimulated with CpG or anti-IgM alone or with both, inhibitors of glycolysis and oxidative phosphorylation decreased both survival ( Fig. 1j ) and activation, as measured by expression of the activation marker CD69 ( Supplementary Fig. 3d ). To gain insight into the metabolic state of B cells at 24 h after stimulation, we measured the OCR by a mitochondrial stress test and measured the ECAR by a glycolytic stress test of live B cells sorted by flow cytometry after 24 h of culture. The baseline OCR of B cells stimulated with CpG alone or with CpG plus anti-IgM was considerably higher and these cells showed greater maximum mitochondrial respiration capacity than that of anti-IgM-treated B cells or unstimulated B cells ( Fig. 2a ). In the glycolytic stress test 15 , cells treated with CpG alone or with CpG plus anti-IgM rapidly responded to the addition of glucose with an increase in the ECAR and, following the addition of antimycin A and rotenone (inhibitors of electron-chain complexes), showed a further increase in the ECAR, suggestive of similar glycolytic reserves. In contrast, untreated and anti-IgM-treated B cells showed little or no increase in the ECAR in response to the addition of glucose ( Fig. 2b) .
To further characterize the metabolic state of live B cells 24 h after stimulation, we measured the mitochondrial membrane potential using staining with the mitochondrial dye TMRM in the presence or absence of oligomycin or the mitochondrial uncoupler FCCP in cells stained with a viability dye. Flow cytometry showed that at 24 h, the mitochondrial membrane potential was greater for B cells under all stimulation conditions than for unstimulated B cells (Fig. 2c,d) . However, the proportion of the maximum mitochondrial potential used differed significantly among the stimulation conditions, with anti-IgM-treated B cells using the greatest proportion of their membrane potential (70%) ( Fig. 2e ), suggestive of mitochondrial stress. We also determined if B cells had undergone cellular metabolic remodeling by 24 h after stimulation. Treatment with CpG alone or with CpG plus anti-IgM resulted in an increase in the expression of GLUT1 and GLUT3 at the level of both protein (Fig. 2f,g) and mRNA (Fig. 2h) . The CpG-mediated increases in the expression of GLUT1 and GLUT3 was dependent on TLR9 signaling and was lost in B cells from mice deficient in TLR9 ( Fig. 2i and Supplementary  Fig. 4c ). Glucose uptake (as measured with fluorescent 2-deoxyglucose (2NBDG)) between 22 h and 24 h after stimulation in vitro showed a hierarchy in glucose levels that reflected the expression of GLUT1 and GLUT3 ( Fig. 2j and Supplementary Fig. 4d ). In contrast, anti-IgM-treated B cells alone showed only modestly higher expression of GLUT1 and GLUT3 or glucose uptake than that of untreated cells.
Both mitochondrial mass and volume also correlate with metabolic activity. We quantified mitochondrial mass by flow cytometry after staining with LIVE/DEAD dye and with antibodies specific for the mitochondrial proteins TOM20, VDAC1 ('voltage-dependent anion channel 1') 18 and COXIV ('cytochrome C oxidase subunit IV') 19 . The greatest increase in mitochondrial mass was evident in B cells stimulated with CpG alone or with CpG plus anti-IgM ( Fig. 3a and Supplementary Fig. 4e ). Immunoblot analysis of the mitochondrial proteins TOM20, Sirt3 ('sirtuin 3') and Hsp60 ('heat-shock protein 60') in lysates of live B cells harvested from cultures at 24 h confirmed those increases in mitochondrial mass (Fig. 3b,c) .
Mitochondrial volumes were determined from three-dimensional reconstructions of high-resolution stimulated-emission-depleted images of B cells cultured for 24 h and then labeled with anti-TOM20 and the mitochondrial dye MitoTracker CMXROS Red (Fig. 3d ). The mitochondrial volume (average values) increased in each stimulation condition, with the largest increases observed for B cells stimulated with CpG alone or with CpG plus anti-IgM (Fig. 3e ).
To assess mitochondrial biogenesis, we analyzed by qPCR the ratio of the DNA of the mitochondrial gene encoding the cytochrome c oxidase subunit COI to the DNA of the nuclear gene encoding the 18S ribosomal subunit. We also measured expression of the gene encoding the mitochondrial transcriptional factor TFAM 20 , one of the master regulators of mitochondrial proliferation. We observed both a higher ratio of the gene encoding COI to the gene encoding 18S (Fig. 3f ) and upregulation of the gene encoding TFAM (Fig. 3g) in B cells stimulated in culture for 24 h with CpG alone or CpG plus anti-IgM, relative to that in unstimulated B cells, indicative of an increase in mitochondrial biogenesis. In contrast, stimulation with anti-IgM alone did not induce an increase in mitochondrial biogenesis.
BCR signaling results in mitochondrial dysfunction in vitro.
To further explore mitochondrial function in B cells stimulated with anti-IgM, we used a second mitochondrial dye, MitoTracker Green. MitoTracker Green is used as a measure of mitochondrial mass 10,21-25 , but staining with this dye can also indicate mitochondrial injury and swelling 26, 27 . Only B cells activated with anti-IgM showed an increase in MitoTracker Green staining over 72 h of culture (Fig. 4a,b) , despite the fact that we observed significant increases in mitochondrial mass in cells treated with CpG alone or with CpG plus anti-IgM (Fig. 3a-c) Additionally, MitoTracker Green, as expected, localized specifically to mitochondria only ( Supplementary Fig. 5a ), and intensity differences between groups did not result from cell proliferation ( Supplementary Fig. 3b,c) , which ruled out the possibility of non-mitochondrial causes that might lead to changes in staining and suggested that the dye indicated mitochondrial injury or swelling, not mitochondrial mass, in this setting. In B cells from TLR9-deficient mice, treatment with either anti-IgM or anti-IgM plus CpG resulted in staining with MitoTracker Green (Fig. 4c and Supplementary Fig. 5b ), which suggested that TLR9 signaling prevented the anti-IgM-induced increases in staining. Staining with MitoTracker Green seemed to be a direct consequence of BCR signaling, as treatment of B cells with the Syk inhibitor piceatannol or with the Btk inhibitor ibrutinib at 8 h after stimulation diminished the staining of anti-IgM treated cells with MitoTracker Green at 24 h ( Fig. 4d and Supplementary Fig. 5c ).
It has been well documented in multiple biological systems that dysregulation of reactive oxygen species (ROS) and/or calcium homeostasis lead(s) to mitochondrial swelling, and that the resulting mitochondrial dysfunction further aggravates the irregularities in ROS and calcium in a positive feedback cycle, which leads to death of the cell [28] [29] [30] [31] [32] . Using CellROX, a fluorescent sensor of cellular oxidative stress 33 , we observed an increase in its mean fluorescent intensity only in anti-IgM-stimulated B cells at 24 h after activation (Fig. 4e,f) . Staining with MitoSOX, a fluorescent superoxide sensor of mitochondrial ROS production 34 , also increased under each stimulation condition, as expected, given the increased mitochondrial function, but an excessive increase in staining with MitoSOX was observed in B cells stimulated with anti-IgM alone (Fig. 4g,h) . The anti-IgM-induced increase in MitoSOX staining was a direct consequence of BCR signaling and was blocked by treatment with piceatannol or ibrutinib ( Fig. 4i and Supplementary Fig. 5d ). To assess the integrity of mitochondria, we measured the ability of the mitochondria to remove excess intracellular calcium by the calcium-retention capacity assay of permeabilized cells 35 , measuring the fluorescent calcium sensor Calcium Green 5N. B cells treated with CpG or with CpG plus anti-IgM were able to remove excess pulsed calcium efficiently through the first three pulses (Fig. 4j) . In contrast, anti-IgM-treated B cells, despite also having greater mitochondrial contents than unstimulated B cells had, had little capacity to remove excess calcium. The inability of the mitochondria to remove excess calcium correlated with higher levels of intracellular calcium in B cells cultured for 24 h with anti-IgM than in untreated B cells ( Fig. 4k and Supplementary Fig. 5e ).
Electron microscopy of B cells cultured for 24 h in vitro with anti-IgM confirmed mitochondrial injury, showing focal loss of cristae and swollen or vesicular swollen matrix areas, alternating with normal mitochondrial structures (Fig. 4l ). In contrast, unstimulated B cells and B cells stimulated with CpG or with CpG plus anti-IgM showed normal mitochondrial morphology.
Thus, BCR signaling induced mitochondria dysfunction that correlated with MitoTracker Green staining, as shown by increased ROS production; an increased percentage of the maximum mitochondrial membrane potential; increased superoxide production; decreased capacity of the mitochondria to remove excess calcium; increased intracellular calcium levels; and abnormal mitochondrial morphology.
Antigen induces B cell mitochondrial dysfunction in vivo.
To determine if engagement of antigen alone by B cells induced mitochondrial dysfunction in vivo, we obtained polyclonal B cells from CD45.1 + wild-type mice or HEL-specific B cells from CD45.2 + MD4 mice, stained the cells with the fluorescent cell-proliferation dye e450, adoptively transferred the cells into wild-type CD45.2 + host mice and, 24 h later, immunized the host mice with PBS, HEL or CpG alone or HEL plus CpG ( Supplementary Fig. 6a,b) . We harvested spleens from the host mice 24 h later and analyzed the adoptively transferred B cells by flow cytometry. Polyclonal wild-type B cells responded to CpG alone and to CpG plus HEL but not to HEL alone, as shown by an increase in the expression of CD69 (Fig. 5a ), but they did not stain with MitoTracker Green (Fig. 5b,c) . In contrast, HEL-specific B cells increased their expression of CD69 in response to HEL alone and to CpG alone and showed an enhanced response to the combination of CpG and HEL (Fig. 5a ). However, only HEL-specific B cells that responded to HEL alone stained with MitoTracker Green (Fig. 5b,c) and showed increases in both intracellular calcium, as measured by Calcium Green 5N AM (Fig. 5d,e) , and ROS levels, as measured with MitoSOX ( Fig. 5f,g) . Thus, the BCR-induced mitochondrial dysfunction observed in vitro was recapitulated in vivo.
The quality of BCR stimulation dictates mitochondrial dysfunction. Mitochondrial dysfunction, as measured by staining with MitoTracker Green, was significantly higher in B cells exposed to continuous stimulation with anti-IgM for 24 h than in B cells that received only a pulse of anti-IgM ( Fig. 6a and Supplementary Fig. 7a ). We also compared the responses of HEL-specific B cells to HEL presented in three different contexts: on PLBs; on plasma membrane sheets (PMSs) 36 ; and to transfected cell lines expressing membranebound HEL on their surfaces 37 . HEL in each context induced similar mitochondrial dysfunction in HEL-specific B cells, as measured by an increase in staining with MitoTracker Green (Fig. 6b) .
To determine the effect of antigen affinity on the induction of mitochondrial dysfunction, we incubated B cells with NIH3T3 mouse fibroblasts expressing CD4 chimeric proteins containing HEL, duck egg lysozyme (DEL) or one of three different previously characterized mutant forms of HEL [38] [39] [40] . The affinity of HEL-specific B cells for HEL, DEL and the three HEL mutants ranged over 3,500fold ( Supplementary Fig. 7b ). We observed no significant difference in the induction of mitochondrial dysfunction in B cells in response to antigens of different affinities (Fig. 6c ), which suggested that this function of the BCR was relatively affinity independent.
To assess the effect of antigen avidity and the strength of BCR cross-linking on BCR-induced mitochondrial dysfunction, we incubated B cells with streptavidin-coated beads that displayed increasing amounts of anti-IgM, with ovalbumin (OVA) as a 'filler' , as verified by flow cytometry (Fig. 6d ). We observed a strong positive correlation between the density of anti-IgM displayed on the beads and the activation of B cells, assessed as expression of the B cell-activation markers CD25, CD86 and CD69, after 24 h of incubation (Fig. 6e ). We observed a positive correlation between the density of anti-IgM displayed on the beads and mitochondrial dysfunction, as measured by staining with MitoTracker Green (Fig. 6f ) and Calcium Green 5 N AM (Fig. 6g) , and a negative correlation with B cell viability ( Fig. 6f,g) .
It is of interest that the viability of B cells stimulated with beads displaying anti-IgM was less than that of B cells incubated with 'OVA-only' beads at all concentrations of anti-IgM tested (Fig. 6f,g) . Thus, in this culture system, BCR-activation-induced cell death (AICD) of primary naive B cells could be distinguished from the death of unstimulated cells, which provides the first evidence, to our knowledge, of AICD in primary B cells.
Both TLR9 signaling and T cell help block AICD. We sought to determine how long the addition of CpG to anti-IgM-treated B cells could be delayed with the viability and mitochondrial function B cells still maintained at 24 h. In the absence of CpG (addition at 24 h), anti-IgM-treated B cells showed considerable staining with
MitoTracker Green and reduced viability (Fig. 6h ). Cells to which CpG was added as late as 9 h after stimulation with anti-IgM showed staining with MitoTracker Green close to background levels and showed nearly 80% viability at 24 h (Fig. 6h) . After approximately 9 h, B cells showed increasing staining with MitoTracker Green and decreasing viability even in the presence of CpG. Thus, anti-IgMinduced mitochondrial dysfunction and cell death seemed to be a cumulative process that could be blocked by early TLR9 signaling.
To determine whether helper T cells could similarly block BCRinduced mitochondrial dysfunction, we cultured HEL-specific MD4 B cells for 24 h either alone or together with helper T cells from 3A9 mice, which have transgenic expression of a HEL-specific TCR, or with 3A9 T cell hybridomas, in the presence or absence of HEL. The addition of HEL alone to HEL-specific B cells resulted in increased staining with MitoTracker Green (Fig. 7a,b) and MitoSOX (Fig. 7c,d ) and increased intracellular calcium levels, as measured with the fluorescent calcium indicator Fluo-4FF AM (Fig. 7e,f) , indicative of mitochondrial dysfunction that was not observed in the presence of HEL-specific helper T cells. We also observed that CD40L alone was sufficient to block the anti-IgM-induced increases in staining with MitoTracker Green (Fig. 7g,h) and cell death (Fig. 7i) to an extent similar to that achieved with CpG.
Increases in intracellular calcium cause mitochondrial dysfunction.
The results presented thus far demonstrated that prolonged BCR stimulation resulted in loss of mitochondrial function. Wellcharacterized causes of mitochondrial dysfunction include excessive increases in intracellular ROS and calcium, both of which we demonstrated were induced by BCR signaling (Figs. 4 and 5) . To determine the contributions of ROS production to mitochondrial dysfunction, we analyzed by qPCR transcriptional changes in the expression patterns of genes encoding several cellular oxidases and antioxidants, at 4 h after stimulation. The most substantial increases were in the expression of genes encoding glutathione reductase (Gsr) and both cytoplasmic and mitochondrial forms of superoxide dismutase (Sod1 and Sod2) that occurred in B cells treated with CpG or with CpG plus anti-IgM but not in those treated with anti-IgM alone (Fig. 8a) . SOD-2 was of particular interest, as it has a central role in neutralizing superoxide produced by the activity of the electron-transport chain 41 . We measured SOD-2 activity in the mitochondrial fractions of stimulated B cells and observed increases in B cells responding to CpG or to CpG plus anti-IgM but not in those responding to anti-IgM alone (Fig. 8b) . This observation suggested the possibility that mitochondrial dysfunction resulted from excess accumulation of ROS in the absence of increases in SOD-2 in B cells stimulated through the BCR. If that were true, we predicted that treatment of anti-IgM-activated B cells with antioxidants to diminish the abundance of ROS would reduce mitochondrial dysfunction. We assessed the antioxidants N-acetyl cysteine, α -tocopherol and l-ascorbic acid, either alone or in combination, as well as the mitochondria-targeted antioxidant MitoTEMPO, over a range of concentrations and duration of exposure. None prevented mitochondrial dysfunction (Fig. 8c ), which suggested that ROS production might be a consequence, not a cause, of mitochondrial dysfunction. In contrast, in B cells activated by anti-IgM alone, decreasing the levels of calcium through the use of the calcium chelator BAPTA AM at 8 h or 16 h after stimulation significantly diminished staining with both MitoSOX (Fig. 8d,e ) and MitoTracker Green (Fig. 8f,g) . In addition, SKF96365, a broad-range inhibitor of transient response potential channels 42, 43 , and YM58483, a highly specific inhibitor of store-operated calcium-entry channels that blocks calcium-response-activated calcium channels 1, 44 , blocked the anti-IgM-induced increases in staining with Calcium Green 5 N AM ( Fig. 8h and Supplementary Fig. 7c ), MitoTracker Green ( Fig. 8i and Supplementary Fig. 7d ) and MitoSOX ( Fig. 8j and Supplementary  Fig. 7e ), when the inhibitors were added up to 8 h after stimulation, for YM58483 ( Fig. 8k ). Together these results revealed a key role for increased levels of intracellular calcium mediated by the activity of calcium-response-activated calcium channels in BCR-induced mitochondrial dysfunction and suggested that the increases in ROS production were a result not a cause of mitochondrial dysfunction.
Discussion
Here we have presented the results of an extensive analysis of metabolic changes in B cells following signaling via the BCR and TLR9 that has not only produced a detailed picture of the metabolic changes induced in B cells in response to activating signals but also provided new insights into the molecular mechanisms that underlie AICD and the two-signal requirement for full activation of B cells. We demonstrated that after engaging antigen, B cells rapidly increased their glycolytic and glucose-oxidative metabolism. At the same time, the B cells began a process of cellular remodeling to increase their mitochondrial and glycolytic capacities, as indicated by changes in the transcriptional patterns of genes encoding molecules that mediate these metabolic processes. We speculate that these changes were in anticipation of a second signal provided either by antigen-specific helper T cells or through TLR9 signaling that induced rapid proliferation and differentiation into antibodysecreting cells. However, in the absence of a costimulatory second signal, at 24 h after stimulation, the mitochondria in BCR-activated B cells lost function, and within 48 h, the B cells underwent apoptosis. Mitochondrial dysfunction seemed to be the consequence of a gradual increase, over hours, in intracellular calcium through the activity of calcium-response-activated calcium channels. We speculate that a positive feedback cycle between mitochondrial calcium levels and ROS production exacerbated the mitochondrial dysfunction, leading to complete dysfunction of mitochondria and the eventual apoptotic death of the B cell. We showed that B cells provided with a second signal within approximately 9 h of the initiation of BCR signaling were rescued from mitochondrial dysfunction. We suggest that the gradual increase in intracellular calcium acts as a 'metabolic clock' that limits the window of time during which BCR-activated B cells must acquire a second signal to survive.
Our description of the apoptosis of B cells following activation through the BCR in the absence of a costimulatory second signal is similar to the phenomenon of AICD in lymphocytes. Understanding AICD in primary naive B cells at a mechanistic level has been difficult, in part because both unstimulated B cells and anti-IgM-stimulated B cells undergo apoptosis at a similar pace in most conditions in vitro, which precludes the ability to correlate death with activation in response to soluble antigens. Consequently, the current understanding of AICD in B lymphocytes has been provided mainly by studies carried out with B cell lines 45 that have provided evidence that AICD is due to growth arrest. Here we sought to determine whether the viability of BCR-activated B cells depends on the strength of BCR stimulation and, if so, whether there is a point at which the apoptosis of B cells activated through the BCR exceeds that of unstimulated B cells. We determined that B cell viability decreased with increasing strength of BCR stimulation and that the survival rate of B cells stimulated with anti-IgM adsorbed onto beads was significantly lower than that of unstimulated B cells, even for the lowest density of anti-IgM tested. To our knowledge, this result provides the first evidence of AICD in primary naive B lymphocytes. Furthermore, these data provide a mechanism for AICD, showing that increased levels of intracellular calcium and mitochondrial dysfunction correlate with AICD.
Here we focused on the effect of BCR signaling on metabolic changes in naive B cells and came to the conclusion that BCR signaling activates metabolic pathways in cells that prepare them for the prospect of receiving a second signal, from antigen-specific helper T cells, for example, that will drive the cell into energy-consuming proliferation and differentiation. In this sense, the BCR is an activating receptor. However, if the B cell fails to acquire a second signal in a restricted time period, the very BCR signals that induced the metabolic change (increases in calcium) begin to act as a 'death clock' that results in apoptosis if not blocked by a second signal. We see BCR-induced activation and apoptosis as two sides of the same coin. Another example of this duality is the ability of the BCR to rescue CD40-activated B cells from apoptotic death mediated by the cellsurface receptor Fas [46] [47] [48] . This mechanism is thought to have a role in the antigen-mediated rescue of bystander B cells that have been inadvertently activated by CD4 + T cells. The findings presented here might also be pertinent to the published observation that TLR9 signaling triggered by CpG antagonizes the ability of naive B cells to process and present antigen to helper T cells, both in vitro and in vivo, and to acquire a second signal that allows affinity maturation 16 . Given those findings and the results presented here, we propose that TLR9 agonists block the presentation of antigen by B cells to follicular helper T cells and consequently block the acquisition, by B cells, of a second signal from T cells. At the same time, TLR agonists independently provide a second signal to cells secreting lowaffinity antibody and promote their proliferation and differentiation.
In summary, the results reported here not only provide new information about the metabolic remodeling that accompanies B cell activation and its timeline but also put such changes in the context of the two-signal model of B cell activation and AICD. We conclude that B cells undergo metabolic changes following antigen engagement in preparation for the energetic and metabolic requirements of proliferation and differentiation that result from the provision of a second signal. However, as a safeguard, if BCR-activated B cells cannot acquire a second signal, they undergo apoptosis triggered by the very events that prepare the cells for full activation.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0156-5.
Animals and cells. C57BL/6 (Stock No: 00664), B6 CD45.1 (Pep Boy) (Stock No: 002014) and B10.BR (Stock No:00465) were purchased from Jackson Laboratory. MD4 mice (with transgenic expression of a HEL-specific BCR) were purchased from Taconic Farms. TLR9-deficient mice were provided by S. Bolland (NIAID, NIH). 3A9 mice (with transgenic expression of a HEL-specific TCR) were provided by I. Gery (NEI, NIH). MD4 mice were either kept on MHC class II H-2A b haplotype (for in vitro B cell-stimulation experiments and adoptive transfer) or on the MHC class II H-2A b × H-2A k haplotype (for B cell-T cell co-culture experiments) by breeding with the B6 strain or B10.BR strain, respectively. All mice were bred and maintained at NIAID animal facilities according to Animal Care and Use Committee (ACUC) standards. Experiments involving mice were approved by NIH ACUC.
The NIH3T3 mouse fibroblast cell line (ATCC CRL-1658) and 3A9 mouse T cell hybridoma line (ATCC CRL-3293) were provided by O. Voss (NIAID, NIH) and P. Allen (Washington University), respectively. The Phoenix Eco retroviral packaging cell line (ATCC CRL-3214) was purchased from American Type Culture Collection. B cells and naive T cells were purified from mouse spleens using negative magnetic selection strategies explained in detail elsewhere 49, 50 . Cells were maintained in vitro in complete culture medium (RPMI 1640 medium supplemented with 10% FCS, 10 mM HEPES, pH 7.3, 50 U/ml penicillin, 50 μ M streptomycin, 2 mM l-glutamine, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate and 50 μ M β -mercaptoethanol) in a humidified 5% CO 2 tissue culture incubator at 37 °C unless otherwise specified.
Reagents and antibodies. ODN 1826 (Invivogen) was used for TLR-9 stimulation. F(ab′ ) 2 donkey anti-mouse IgM (catalog no: 715-006-020) (Jackson ImmunoResearch) or HEL (Sigma-Aldrich) were used for BCR stimulation. Recombinant multimeric mouse CD40L (AdipoGen Life Sciences) was used to simulate T cell help. Biotinylated anti-mouse IgM (catalog no: 115-066-075) (Jackson ImmunoResearch), biotinylated OVA (Nanocs) and streptavidin-coated particles (SVM025-5H) (Spherotech) were used in bead-based stimulation assays. 2-deoxy-d-glucose (2-DG) (Sigma-Aldrich) and oligomycin (Cell Signaling Technology) were used to inhibit metabolic pathways. Piceatannol, SB202190, SP600125, wortmannin, PD98059 and perifosine (InvivoGen) were used to inhibit signaling activities of Syk, p-38, JNK, PI3K, MEK1/2 and Akt, respectively. N-acetyl cysteine (Sigma-Aldrich), α -tocopherol, l-ascorbic acid (Sigma-Aldrich) and MitoTEMPO (ThermoFisher) were used as antioxidants in certain experiments. The cell-permeant calcium chelator BAPTA AM (ThermoFisher) and ion-channel blockers SKF96365 and YM58483 (Sigma-Aldrich) were used to address the role of calcium in BCR-mediated mitochondrial changes. Flowcytometry assessment of the internalization and/or compartmentalization of BCR-bound antigen was carried out by coating MD4 B cells with biotinylated HEL (Sigma-Aldrich) conjugated to pHrodo Red Avidin (ThermoFisher) on ice and then monitoring the change in red fluorescence due to internalization after bringing the cells back to 37 °C. 2NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose; ThermoFisher) was used to assess the real-time glucose uptake of cells by flow cytometry. Antibodies to the following were used in various flow-cytometry experiments: CD19 (clone: 6D5), CD69 (clone: H1.2f3), CD4 (clone: RM4-5), CD45.1 (clone:A20), CD45.2 (clone:104), CD25 (clone: PC61), CD16/32 (clone 93), B220 (clone:RA3-6B2) and CD86 (clone: GL-1) (all from BioLegend); ovalbumin (catalog no: Ab85584),TOM20 (clone F10), COXIV (clone: 20E8C12) and VDAC1 (clone: N152B/23) (all from Abcam); and goat IgG light chain (catalog no:205-602-176) and mouse IgG2a (catalog no:115-607-186) (both from Jackson ImmunoResearch). Analysis of different stages of cell death was carried out using a necrosis vs apoptosis kit (Immunochemistry Technologies) according to the manufacturer's protocol.
Measurement of mitochondrial mass and membrane potential.
Flow-cytometry measurement of mitochondrial mass was carried out by staining the cells with a LIVE/DEAD fixable dead cell stain (ThermoFisher) and phenotyping antibodies, if required, followed by fixation and permeabilization using the BD Cytofix/ Cytoperm kit (BD Biosciences). Permeabilized cells were then stained with antibodies to mitochondrial markers. For markers that require permeabilization of mitochondrial membranes, a 1/100 dilution of Triton X-100 was used. For detection of mitochondrial mass using immunoblot analysis, cultured cells were stained with the LIVE/DEAD marker and live cells were sorted by flow cytometry. Equal numbers of live cells from different conditions were lysed using RIPA buffer, separated by SDS-PAGE and transferred to nitrocellulose membranes. Antibodies to the following were used: β -actin (A1978, Sigma-Aldrich), HSP60 (4870S, Cell Signaling Technology), SIRT3 (5490S, Cell Signaling Technology) and TOM20 (sc-11415, Santa Cruz Biotechnology). SeeBlue Plus2 Pre-stained protein standard (ThermoFisher) was used for band-size estimation. Images were captured using the Odyssey system (Li-Cor) .
For mitochondrial membrane potential measurement, cells were cultured in 96-well plate in phenol red-free culture medium at a density of 2.5 × 10 5 cells per well at 37 °C for the required amount of time. A final concentration of 6 μ M oligomycin or 5 μ M FCCP was added each to one of the three wells of containing identically cultured cells. An equal volume of medium was added to the third well. After 10 min of incubation at 37 °C, tetramethylrhodamine, methyl ester, perchlorate (TMRM) (ThermoFisher) was added to all wells at a final concentration of 30 nM, and Sytox Blue Dead Cell Stain (ThermoFisher) was added at 1 μ M. Following an additional 30 min of incubation, cells were rapidly analyzed by flow cytometry. The percentage of the maximum mitochondrial potential was calculated using the following algorithm: [100× (MFI (TMRM alone) -MFI (TMRM+FCCP) )/ (MFI (TMRM + oligomycin) -MFI (TMRM+FCCP) )].
qPCR. For analysis of gene expression using qPCR, RNA was isolated from in vitro-cultured B cells using an RNeasy Plus Micro Kit (Qiagen), cDNA was generated using iScript Reverse Transcription Supermix (Bio-Rad) and, depending on the choice of primers, either an iQ SYBR Green Supermix kit (Bio-Rad) or a Platinum Quantitative PCR SuperMix-UDG kit (ThermoFisher) was used to amplify the target genes. Analysis of the change in expression (target over control) was carried out using the comparative CT method. The list of primers and probes are in Supplementary Table 1 . For quantification of the ratio between mitochondrial and genomic DNA, DNA was isolated from cultured B cells using DNeasy Blood and Tissue Kit (Qiagen) and qPCR was carried out with different dilutions of DNA using iQ SYBR Green Supermix.
Measurement of ROS production and MitoTracker green fluorescence. For
MitoTracker Green staining, cultured cells were re-suspended in RPMI without phenol red supplemented with 2% FCS, 1% HEPES, pH7.3 and 1/250 dilution of LIVE/DEAD Fixable Near IR dye (ThermoFisher). Cells were incubated at 4 °C for 20 min. After the incubation, cells were washed and resuspended with pre-warmed freshly made MitoTracker stain buffer (RPMI without phenol red supplemented with 2% FCS, 1% HEPES, pH 7.3, and 40 nM MitoTracker Green (ThermoFisher)). Following incubation at 37 °C for 30 min, cells were spun down and resuspended with RPMI without phenol red supplemented with fresh 2% FCS and 1% HEPES (pH7.3) and were immediately analyzed by flow cytometry. MitoSOX staining was carried out in HBSS supplemented with 5 μ M MitoSOX Red (ThermoFisher) at 37 °C for 30 min. Cells were then washed three times with plain HBSS and resuspended with HBSS supplemented with 1 μ M SYTOX Blue Dead Cell Stain for an additional 10 min of incubation at 37 °C. At the end of this incubation, cells were rapidly analyzed in flow cytometry. CellROX staining was carried out after washing the cultured cells once and resuspending them in full growth medium prepared with phenol red free RPMI and supplemented with 500 nM CellROX (ThermoFisher). Cells were incubated at 37 °C for 45 min. Sytox Blue was added at 1 μ M (final concentration) during the final 10 min of the incubation. Following this, cells were rapidly analyzed on a BD LSR II flow cytometer.
Injection and immunization.
For adoptive transfer experiments, B cells purified from spleens of CD45.1 + wild-type mice and CD45.2 + MD4 mice were mixed at a 1:1 ratio, stained with e450 cell-proliferation dye (ThermoFisher) according to the manufacturer's recommendations and resuspended in PBS. 200 μ l PBS containing 4.5 × 10 6 e450-stained B cells were transferred into a CD45.2 + wild-type mouse via tail-vein injection. At 24 h after transfer mice were given injection of 200 μ l PBS alone or PBS supplemented with ODN1826 (95-100 μ g per mouse) and/or HEL (100 μ g per mouse). At 24 h after stimulation spleens were harvested and splenocytes were used in downstream assays.
Extracellular flux assay. For extracellular flux assays, we used a standardized protocol to measure OCR and ECAR by a Seahorse XF 96 analyzer as described 15 . In brief, 5 × 10 5 B cells per well were resuspended in Seahorse medium and plated in 96-well Seahorse plates coated with Cell-Tak (Corning). Cells were maintained at 37 °C in a non-CO 2 incubator for at least 1 h before the assay. For the mitochondrial stress test, cells were treated sequentially with 1 μ M oligomycin (an inhibitor of the ATP synthase), 0.1 mM 2,4-dinitrophenol (DNP, an uncoupler) and 1 μ M rotenone plus 1 μ M antimycin A (inhibitors of complex I and III of the respiratory chain, respectively). For the glycolysis stress test, glucose-starved cells were treated sequentially with 10 mM glucose, 1 μ M rotenone plus 1 μ M antimycin A and 50 mM 2-DG, an inhibitor of glycolysis. SOD-2 and PDH activity assay. SOD activity was tested in equal numbers of live B cells using the SOD assay kit (Cayman Chemical). To ensure the detection of only Mn-SOD (SOD-2) activity, 5 mM potassium cyanide was added to the assay to inhibit the activities pf cytosolic Cu/Zn-SOD (SOD-1) and extracellular Cu/Zn-SOD (SOD3).
PDH activity was measured using a PDH Enzyme Activity Microplate Assay Kit (Abcam) according to the manufacturer's guidelines using the lysates of B cells stimulated for 6 h in vitro (2.5 × 10 7 cells per condition).
Measurement of cellular calcium levels and mitochondrial calcium uptake.
To measure changes in cellular calcium concentrations, B cells were stained with 2-7 μ M cell-permeant Calcium Green, 5N AM (ThermoFisher) or 2-20 μ M Fluo-4FF AM (ThermoFisher), together with LIVE/DEAD stain and phenotyping antibodies at 4 °C for 20 min. Cells were then washed and analyzed by flow cytometry.
Mitochondrial calcium uptake was measured using a strategy described elsewhere 51 . In brief, in vitro-cultured B cells were stained with LIVE/DEAD Near IR and sorted by flow cytometry for live cells. 2 × 10 6 viable cells per condition were resuspended in 100 μ l intracellular buffer (containing 10 mM HEPES, pH 7.2, 0.25 M sucrose, 2 mM K 2 HPO 4 and 1 mM DTT). Cell-impermeant-Calcium Green 5 N (ThermoFisher) was added to the suspension at 0.1 μ M final concentration. Digitonin was then added at 100 μ M final concentration to permeabilize the cells, and mitochondria were energized by the addition of succinate (5 mM) plus rotenone (1 μ M). A FLUOstar Omega Microplate Reader (BMG LABTECH) provided with temperature control (30 °C) and continuous stirring was used to monitor the fluorescence of Calcium Green (excitation 506 nm, emission 532 nm) and, thus, the extramitochondrial calcium. Cells were pulsed with calcium chloride (20 μ M per pulse), and calcium uptake into mitochondria was monitored in real time (as a decrease in fluorescence) until the onset of permeability transition.
Preparation of antigen containing plasma membrane sheets (PMSs) and planar lipid bilayers (PLBs). PMSs were prepared from 293A cells as a protocol previously described 36 . PMSs plated on coverglass were sequentially incubated with 0.5 μ g/ml biotinylated annexin V (BioLegend), 5 μ g/ml streptavidin (ThermoFisher) and 50 nM Alexa Fluor 488-conjugated biotinylated HEL, with washing between steps with 15 ml HBSS solution containing 0.2% BSA and 2.5 mM Ca 2+ . PLBs containing biotinylated lipids were generated as previously described 52 . 10 nM Alexa Fluor 488-labeled biotinylated HEL was added to PLB and was incubated at RT for 30 min in order to facilitate incorporation. At the end of this period, unbound HEL was removed by washing.
Preparation of PLB-bound antigen, total internal reflection fluorescence imaging and image analyses. Time-lapse live-cell total internal reflection fluorescence imaging of splenic B cells from MD4 mice labeled for surface BCR with goat Fab anti-mouse IgM conjugated to DyLight 549 (115-507-020, Jackson Immunoresearch) and placed on HEL-containing PLB was performed as described 53 . Image acquisition began right after the cells touched the surface and recorded and an interval of 7 s for 30 min. Image J software was used for the determination of the change in BCR accumulation (fold values) on the contact site and size of contact area. Background subtraction and then threshold setting for the positive signals above background noise were performed for all images before the measurement of BCR MFI and contact area using ImageJ FIJI software. BCR accumulation was determined by the change in BCR MFI (fold values) at a given time relative to that of the clusters at the first contact time point. The effect of metabolic inhibitors was compared by the B cell response in the absence or the presence of either 55 mM 2-DG or 6 μ M oligomycin in a PLB-Ag chamber.
Generation of NIH3T3 cell lines expressing recombinant lysozyme proteins.
DNA constructs containing full-length codon optimized sequences encoding wildtype HEL (NCBI accession code AAA48943.1) or wild-type duck egg lysozyme (DEL) (NCBI accession code 0802160A), followed by a serine-threonine linker and then by the third and fourth transmembrane and intracellular domains of rat CD4 (residues 206-457) (NCBI accession code P05540.1) were synthesized by Geneart Gene Synthesis (ThermoFisher). Constructs containing different affinity mutations of HEL were generated simply by making mutations encoding the appropriate substitution(s) (K97A for HEL-K; R21A, D101A for HEL-RD; and R21A, D101A, G102A, N103A for HEL-RDGN) on the initial wild-type HEL design. The numbers refer to the positions of the relevant amino acids after removal of the leader sequence. The final constructs were subcloned into a Pfb-Hygro retroviral vector. Phoenix Eco packaging system was used to generate viruses for transducing NIH3T3 cells. Transduction and hygromycin selection of NIH3T3 cell line was carried out as outlined before 54 .
Stimulated-emission-depleted (STED) microscopy.
In vitro cultured B cells were stained with LIVE/DEAD Green (ThermoFisher) and MitoTracker Red CMXROS (at 150 nM final concentration) (ThermoFisher), as explained above for MitoTracker Green. Cells were then resuspended in HBSS, and 1 × 10 6 cells were added to coverslips previously coated with poly-l-lysine (Sigma-Aldrich) and were incubated at RT for 10 min. Unbound cells were removed and cover slips were blocked by washing twice with staining buffer (HBSS supplemented with 1% HEPES, pH 7.3, 2% heat-inactivated FCS and 0.09% sodium azide). Cells were then fixed and permeabilized using a BD CytoFix/Cytoperm Kit (BD Biosciences). Intracellular staining for TOM20 was carried out using rabbit anti-mouse TOM20 (catalog no: 56783) (Abcam), followed by the secondary antibody ATTO-647N-conjugated anti-rabbit IgG (catalog no: 40839) (Sigma-Aldrich). DAPI staining was done next in PBS containing 300 nM DAPI for 5 min. Following a wash, mounting solution, prepared by mixing Mowiol 4-88 (Milipore Sigma) with p-phenylenediamine according to the manufacturer's guidelines, was used to mount the coverslips onto the slides. Images were collected on a Leica TCS SP8 STED 3 × system equipped with white light and UV excitation lasers, a pulsed 775 nm depletion laser, a HC PL APO 100 × /1.40 oil STED white objective, and gated HyD detectors. Images were further deconvolved using Huygens deconvolution software. Volumes smaller than 0.01 μ m 3 were arbitrarily excluded from the analysis, but the results of excluded and non-excluded volumetric analysis were similar (data not shown).
Imaging of MitoTracker Green staining using confocal microscopy. B cells purified from wild-type C57BL/6 mice were in vitro cultured in various activation conditions for 24 h. Cells were then washed with plain RPMI 1640 medium without phenol red and stained with LIVE/DEAD Fixable reagent (ThermoFisher) at 4 °C for 30 min, followed by MitoTracker Green staining. After one wash, cells were plated onto poly-l-lysine-coated eight-chamber Lab-Tek II chambered #1.5 German coverglass system (Nunc). After 5 min of incubation at 37 °C, medium was aspirated and replaced with complete culture medium prepared with RPMI without phenol red (400 μ l per chamber). The plate was then placed into a Zeiss LSM 780 confocal microscope enclosed inside a 37 °C, 5% CO 2 humidified incubation chamber, and z-stack images were acquired.
Transmission electron microscopy. In vitro-cultured B cells were fixed in Karnovsky's fixative (Electron Microscopy Sciences) and processed according to a published microwave irradiation strategy 55 with the following modifications: Cells were centrifuged at 800 g between steps, cells were infiltrated in Araldite resin (SPI) and tomography sections were cut at 150-nm thickness and imaged with no post-section staining. An Ultrascan 4000 camera (Gatan) with SerialEM acquisition and control software (University of Colorado) 56 was used to collect the tomographic tilt series.
Data analysis. Flow-cytometry data was analyzed using Flowjo software (Tree Star). Confocal and STED microscopy data were analyzed using Imaris (Bitplane). Dead cells were excluded from both microscopy and flow cytometry analyses based on their staining with the relevant live-dead marker. Statistical significance analyses were carried out using The R Project 3.4.3, JMP 13.2.0 and GraphPad Prism 7.03 software. The statistical methods used for each experiment were indicated in relevant figure legend. In brief, many datasets were tested with repeated-measures mixed model two-way ANOVA using Tukey-adjusted post-hoc tests or Dunnett-adjusted post-hoc tests against the unstimulated or no-treatment control group. Fixed-effect one-way ANOVA with Tukey's adjustment was used in single-factor experiments, where repeated sampling over time was not used. Sometimes multiple-fixed-effect one-way ANOVAs were paneled over multiple independent experiments. In other examples, fixed-effect one-way ANOVA was only used on anti-IgM samples, because unstimulated controls were constrained to onefold change in MFI and were included on the graph only as reference groups. Linear regression, cubic polynomial regression, Kendall's tau correlations and Pearson's correlations were used in situations where it seemed more relevant to compare the shape or direction of a relationship. Multiple Bonferroni-adjusted one-sided t-tests were used when it was most important to identify groups with responses higher than the unstimulated or untreated control group. Nonparametric Mann-Whitney tests were used when the normal distribution of data was in doubt. Welsh-corrected Student's t-tests were used in situations where single independent experiments were compared. In all figures, ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05 and NS (P > 0.05) are used to denote statistical significance. Corresponding author(s): Susan K. Pierce
Life Sciences Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Please do not complete any field with "not applicable" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.
Experimental design 1. Sample size
Describe how sample size was determined.
Sample size was determined based on previous studies of similar nature.
Data exclusions
Describe any data exclusions.
No data exclusions have been made
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
All experiments were repeated and experiments contained duplicates, triplicates etc. Key experiments were repeated by different authors at different times using different reagent stocks to minimize batch error and maximize reproducibility. For consistent results, slight optimizations in protocols of experiments involving calcium and ROS stains and CD40L were carried out for each batch. Freeze-Thaw cycles and extended storage were strictly avoided. Once the measures specified above were taken, experiments were reproducible.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For adoptive transfer experiments, age-sex matched animals were used. Animals were randomly assigned to experimental groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Injections were carried out by our animal technician who was given single-blinded barcoded samples. She did not know which groups took what treatment.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
